Pharmnovo AB

PharmNovo is a pharmaceutical company at the clinical stage of developing a unique type of treatment for nerve pain (neuropathic pain), a condition currently lacking effective and safe treatment. The company is currently finalising its clinical phase I study and is advancing its preparations for a phase II study.

pharmnovo.com
LinkedIn

Press release:
Sciety and Sciety Venture Partners invest in PharmNovo